DermTech International (“DermTech”), a privately held molecular diagnostics company commercializing non-invasive gene expression tests for dermatology, announced today that it has added three members to its commercialization team. Art Wampole will lead the company’s sales effort, Annie Bell will lead the company’s marketing strategy, and Mildred Romero will lead the company’s reimbursement implementation.
Help employers find you! Check out all the jobs and post your resume.
